The MHRA has approved donidalorsen for long-term prevention of hereditary angioedema, a rare disorder causing potentially life-threatening swelling.
Medscape News UK
Source link : https://www.medscape.com/viewarticle/mhra-approves-new-prophylactic-rare-swelling-disorder-2026a1000f05?src=rss
Author :
Publish date : 2026-05-11 10:27:00
Copyright for syndicated content belongs to the linked Source.